Item 5.07. Submission of Matters to a Vote of Security Holders.
On October 20, 2022, Champion's Oncology, Inc. (the "Company") held its Annual Meeting of the Stockholders (the "Annual Meeting"). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results were as follows, there being no broker non-votes for any matter:
1. Election of Directors. The seven director nominees named in the Company's 2022 proxy statement were elected to serve for a one-year term expiring at the 2023 Annual Meeting of the Stockholders or until their successors are duly elected and qualified, based upon the following votes:
Director Nominee Votes For Votes Withheld Ronnie Morris, M.D. 8,273,790 785,640 Joel Ackerman 8,151,875 907,555 David Sidransky, M.D. 8,032,052 1,027,378 Daniel Mendelson 8,310,539 748,891 Robert Brainin 8,449,790 609,640 Scott R. Tobin 8,982,206 77,224 Philip Breitfeld, M.D. 8,273,990 785,440
2. Ratification of Appointment of Independent Registered Accounting Firm. The appointment of EisnerAmper LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending April 30, 2023, was ratified as follows:
Votes For Votes Against Abstain 9,231,979 572 16
3. Non-binding Advisory Resolution Relating to the Compensation of the Company's Named Executive Officers. The proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as described in the Company's 2022 proxy statement, was approved by the following votes:
Votes For Votes Against Abstain 9,025,636 30,235 3,559
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses